Although there is evidence that changes in Rubicon expression levels in common metabolic diseases such as Non-alcoholic fatty liver disease (NAFLD) are caused by m6A modification (Peng et al., 2022), it has not been determined whether the underlying mechanisms controlling Rubicon expression levels in DKD are similar to those in NAFLD. This evidence concerns the gene RUBCN and metabolic dysfunction-associated steatotic liver disease.